Overview
- 157 inspections across 130 sites are on record.
- 243 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2021-12-16.
At a glance
Inspections
157
Sites
130
Observations
243
Career since
Mar 2008
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| MSN PHARMACEUTICALS INC. | 16 Dec 2021 | Human Drugs | |
| MSN PHARMACEUTICALS INC. | 9 Dec 2021 | Human Drugs | |
| Carnegie Pharmaceuticals, LLC | 19 Nov 2021 | Human Drugs | |
| Cetylite Industries, Inc. | 24 Sep 2021 | Human Drugs | View 483 → |
| CorePharma, LLC | 31 Aug 2021 | Human Drugs |
Sites inspected
MSN PHARMACEUTICALS INC.Piscataway, United States2 insp.
Carnegie Pharmaceuticals, LLCDelran, United States1 insp.
Cetylite Industries, Inc.Pennsauken, United States1 insp.
CorePharma, LLCMiddlesex, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Devon Jenkins6 shared
Ankur C Patel3 shared
Tamil Arasu3 shared
Edmund F Mrak3 shared
Lisa M Bellows3 shared
Jose O Hernandez2 shared
Nancy M Espinal2 shared
Nancy G Schmidt2 shared
Susanna E Ford2 shared
James A Liubicich2 shared
Full investigator report
Get the verbatim findings behind Russell J Glapion's 243 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site